Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases
- Resource Type
- Article
- Source
- In
ESMO Open August 2023 8(4) - Subject
Thoracic Cancers - Language
- ISSN
- 2059-7029